2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation – Web Addenda

[1]  H. Bueno,et al.  Performance of hospitals according to the ESC ACCA quality indicators and 30-day mortality for acute myocardial infarction: national cohort study using the United Kingdom Myocardial Ischaemia National Audit Project (MINAP) register , 2017, European heart journal.

[2]  H. Bøtker,et al.  Quality indicators for acute myocardial infarction: A position paper of the Acute Cardiovascular Care Association , 2017, European heart journal. Acute cardiovascular care.

[3]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[4]  Jeroen J. Bax,et al.  Time course, predictors, and prognostic implications of significant mitral regurgitation after ST-segment elevation myocardial infarction. , 2016, American heart journal.

[5]  J. D. de Lemos,et al.  The association of left ventricular ejection fraction with clinical outcomes after myocardial infarction: Findings from the Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get With the Guidelines (GWTG) Medicare-linked database. , 2016, American heart journal.

[6]  N. Codella,et al.  Echocardiographic Algorithm for Post-Myocardial Infarction LV Thrombus: A Gatekeeper for Thrombus Evaluation by Delayed Enhancement CMR. , 2016, JACC. Cardiovascular imaging.

[7]  E. Boersma,et al.  A simple risk chart for initial risk assessment of 30-day mortality in patients with cardiogenic shock from ST-elevation myocardial infarction , 2016, European heart journal. Acute cardiovascular care.

[8]  J. Tijssen,et al.  Incremental Value of the CRUSADE, ACUITY, and HAS‐BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short Duration of Dual Antiplatelet Therapy , 2015, Journal of the American Heart Association.

[9]  E. Akl,et al.  Surgical versus medical management of patients with acute ischemic mitral regurgitation: a systematic review , 2015, BMC Research Notes.

[10]  Jeroen J. Bax,et al.  2015 ESC Guidelines for the diagnosis and management of pericardial diseases , 2015, European heart journal.

[11]  B. Iung,et al.  Severe secondary mitral regurgitation and left ventricular dysfunction: a 'deadly combination' against which the fight is not over! , 2015, European heart journal.

[12]  Anurag Bajaj,et al.  Acute Complications of Myocardial Infarction in the Current Era , 2015, Journal of Investigative Medicine.

[13]  H. Thiele,et al.  Left Ventricular Thrombus Formation After ST-Segment-Elevation Myocardial Infarction: Insights From a Cardiac Magnetic Resonance Multicenter Study. , 2015, Circulation. Cardiovascular imaging.

[14]  J. Garot,et al.  Incidence, diagnostic methods, and evolution of left ventricular thrombus in patients with anterior myocardial infarction and low left ventricular ejection fraction: a prospective multicenter study. , 2015, American heart journal.

[15]  Marc P. Bonaca,et al.  Long-term use of ticagrelor in patients with prior myocardial infarction. , 2015, The New England journal of medicine.

[16]  G. Lip,et al.  Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials , 2015, BMJ : British Medical Journal.

[17]  Deepak L. Bhatt,et al.  Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis. , 2015, Journal of the American College of Cardiology.

[18]  M. Valgimigli,et al.  Duration of dual antiplatelet therapy after drug-eluting stent implantation: will we ever reach a consensus? , 2015, European heart journal.

[19]  C. Bucciarelli-Ducci,et al.  Magnetic resonance imaging-based management of silent cardiac rupture. , 2015, The Journal of thoracic and cardiovascular surgery.

[20]  T. Jernberg,et al.  Incidence, temporal trends, and prognostic impact of heart failure complicating acute myocardial infarction. The SWEDEHEART Registry (Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies): a study of 199,851 patients , 2015, JACC. Heart failure.

[21]  Braunwald,et al.  Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. , 2014, The New England journal of medicine.

[22]  P. Kirchhof,et al.  Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association , 2014, European heart journal.

[23]  G. Veldtman,et al.  Percutaneous Closure of Postinfarction Ventricular Septal Defect: In-Hospital Outcomes and Long-Term Follow-Up of UK Experience , 2014, Circulation.

[24]  G. Stone,et al.  The prognostic importance of left ventricular function in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial , 2014, European heart journal. Acute cardiovascular care.

[25]  N. Espinola-Zavaleta,et al.  Primary reperfusion in acute right ventricular infarction: An observational study. , 2014, World journal of cardiology.

[26]  J. Zamorano,et al.  The use of echocardiography in acute cardiovascular care: Recommendations of the European Association of Cardiovascular Imaging and the Acute Cardiovascular Care Association. , 2014, European heart journal. Acute cardiovascular care.

[27]  A. Hall,et al.  An evaluation of composite indicators of hospital acute myocardial infarction care: a study of 136,392 patients from the Myocardial Ischaemia National Audit Project. , 2013, International journal of cardiology.

[28]  J. Piek,et al.  Left ventricular thrombus formation after acute myocardial infarction , 2012, Heart.

[29]  S. Neubauer,et al.  Contained left ventricular rupture after acute myocardial infarction revealed by cardiovascular magnetic resonance imaging. , 2012, Circulation.

[30]  Marc P. Bonaca,et al.  Vorapaxar in the secondary prevention of atherothrombotic events. , 2012, The New England journal of medicine.

[31]  J. Marchesini,et al.  Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting: A Randomized Multicenter Trial , 2012, Circulation.

[32]  Paul Burton,et al.  Rivaroxaban in patients with a recent acute coronary syndrome. , 2012, The New England journal of medicine.

[33]  S. Werns.  Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes , 2011 .

[34]  M. Valgimigli.  PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY , 2011 .

[35]  S. Ray.  The echocardiographic assessment of functional mitral regurgitation. , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[36]  H. Arnesen,et al.  Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy. , 2010, The American journal of cardiology.

[37]  C. Catalano,et al.  Right Ventricular Ischemic Injury in Patients With Acute ST-Segment Elevation Myocardial Infarction: Characterization With Cardiovascular Magnetic Resonance , 2010, Circulation.

[38]  J. Tijssen,et al.  Right ventricular dysfunction is an independent predictor for mortality in ST‐elevation myocardial infarction patients presenting with cardiogenic shock on admission , 2010, European journal of heart failure.

[39]  G. Faggian,et al.  Surgical Treatment of Postinfarction Left Ventricular Free Wall Rupture , 2009, Journal of cardiac surgery.

[40]  Claes Held,et al.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.

[41]  Y. Adler,et al.  Frequency and prognostic significance of pericarditis following acute myocardial infarction treated by primary percutaneous coronary intervention. , 2009, The American journal of cardiology.

[42]  R. Collins,et al.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.

[43]  Christopher M O'Connor,et al.  Coronary bypass surgery with or without surgical ventricular reconstruction. , 2009, The New England journal of medicine.

[44]  J. Gore,et al.  Thirty-Year Trends (1975 to 2005) in the Magnitude of, Management of, and Hospital Death Rates Associated With Cardiogenic Shock in Patients With Acute Myocardial Infarction: A Population-Based Perspective , 2009, Circulation.

[45]  R. Lidón,et al.  Changes in Hospital Mortality Rates in 425 Patients With Acute ST-Elevation Myocardial Infarction and Cardiac Rupture Over a 30-Year Period , 2008, Circulation.

[46]  Michael J Pencina,et al.  Long-Term Trends in the Incidence of Heart Failure After Myocardial Infarction , 2008, Circulation.

[47]  M. de Bonis,et al.  Mitral valve surgery in emergency for severe acute regurgitation: analysis of postoperative results from a multicentre study. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[48]  A. Gavazzi,et al.  Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation. , 2008, The American journal of cardiology.

[49]  L. Menicanti,et al.  Effectiveness of surgical ventricular restoration in patients with dilated ischemic cardiomyopathy and unrepaired mild mitral regurgitation. , 2007, The Journal of thoracic and cardiovascular surgery.

[50]  M. Pfisterer,et al.  Hemodynamic parameters are prognostically important in cardiogenic shock but similar following early revascularization or initial medical stabilization: a report from the SHOCK Trial. , 2007, Chest.

[51]  E. Antman,et al.  Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.

[52]  F. Van de Werf,et al.  Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. , 2007, JAMA.

[53]  H. White,et al.  Echocardiographic Predictors of Survival and Response to Early Revascularization in Cardiogenic Shock , 2003, Circulation.

[54]  S. Yusuf,et al.  Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction. , 2001, Journal of the American College of Cardiology.

[55]  L. Sleeper,et al.  Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK? , 2000, Journal of the American College of Cardiology.

[56]  R. Fasol,et al.  Mitral repair in patients with a ruptured papillary muscle. , 2000, American heart journal.

[57]  W. O’Neill,et al.  Effect of reperfusion on biventricular function and survival after right ventricular infarction. , 1998, The New England journal of medicine.

[58]  David Schultz,et al.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996, The Lancet.

[59]  W. O’Neill,et al.  Rapid hemodynamic improvement after reperfusion during right ventricular infarction. , 1995, Journal of the American College of Cardiology.

[60]  O. Topaz,et al.  Interventricular septal rupture complicating acute myocardial infarction: from pathophysiologic features to the role of invasive and noninvasive diagnostic modalities in current management. , 1992, The American journal of medicine.

[61]  B. Gersh,et al.  Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention. , 1992, The American journal of cardiology.